[{"address1": "1100 Campus Road", "city": "Princeton", "state": "NJ", "zip": "08540", "country": "United States", "phone": "609 275 0500", "fax": "609 750 4277", "website": "https://www.integralife.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.", "fullTimeEmployees": 3946, "companyOfficers": [{"maxAge": 1, "name": "Dr. Stuart M. Essig Ph.D.", "age": 61, "title": "Executive Chairman", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 152500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jan  De Witte", "age": 59, "title": "President, CEO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 888667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lea Daniels Knight", "age": 51, "title": "Executive VP & CFO", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 673147, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey A. Mosebrook", "age": 47, "title": "Senior VP of Finance & Principal Accounting Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 493138, "exercisedValue": 0, "unexercisedValue": 408}, {"maxAge": 1, "name": "Mr. Eric Ian Schwartz", "age": 54, "title": "Executive VP, Chief Legal Officer & Secretary", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 549518, "exercisedValue": 0, "unexercisedValue": 1727}, {"maxAge": 1, "name": "Mr. Robert T. Davis Jr.", "age": 64, "title": "Executive VP & President of Tissue Technologies", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 529052, "exercisedValue": 44393, "unexercisedValue": 186792}, {"maxAge": 1, "name": "Mr. Michael J. McBreen", "age": 56, "title": "Executive VP & President of Codman Specialty Surgical", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 611277, "exercisedValue": 0, "unexercisedValue": 1174}, {"maxAge": 1, "name": "Mr. Stephen  Leonard", "age": 61, "title": "Corporate VP of Global Operations & Supply Chain", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Laurene  Isip", "title": "Vice President of Global Corporate Communications & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ruth L. Fleming", "title": "Vice President of Global Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 4, "compensationRisk": 2, "shareHolderRightsRisk": 1, "overallRisk": 1, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 19.51, "open": 19.55, "dayLow": 19.45, "dayHigh": 20.02, "regularMarketPreviousClose": 19.51, "regularMarketOpen": 19.55, "regularMarketDayLow": 19.45, "regularMarketDayHigh": 20.02, "beta": 1.092, "trailingPE": 65.99999, "forwardPE": 7.9199996, "volume": 652399, "regularMarketVolume": 652399, "averageVolume": 1149393, "averageVolume10days": 912760, "averageDailyVolume10Day": 912760, "bid": 19.8, "ask": 19.9, "bidSize": 100, "askSize": 100, "marketCap": 1536123520, "fiftyTwoWeekLow": 16.81, "fiftyTwoWeekHigh": 45.42, "priceToSalesTrailing12Months": 0.9806043, "fiftyDayAverage": 19.1952, "twoHundredDayAverage": 30.17075, "currency": "USD", "enterpriseValue": 3250603008, "profitMargins": 0.0150999995, "floatShares": 66440472, "sharesOutstanding": 77582000, "sharesShort": 4400832, "sharesShortPriorMonth": 4813739, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.056700002, "heldPercentInsiders": 0.03191, "heldPercentInstitutions": 0.95028996, "shortRatio": 4.13, "shortPercentOfFloat": 0.065799996, "bookValue": 19.775, "priceToBook": 1.0012642, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": 23648000, "trailingEps": 0.3, "forwardEps": 2.5, "pegRatio": -1.94, "lastSplitFactor": "2:1", "lastSplitDate": 1483488000, "enterpriseToRevenue": 2.075, "enterpriseToEbitda": 9.121, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "IART", "underlyingSymbol": "IART", "shortName": "Integra LifeSciences Holdings C", "longName": "Integra LifeSciences Holdings Corporation", "firstTradeDateEpochUtc": 808579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "069a3d6c-47d3-32ea-be52-b6fb5f53417c", "gmtOffSetMilliseconds": -14400000, "currentPrice": 19.8, "targetHighPrice": 40.0, "targetLowPrice": 16.0, "targetMeanPrice": 26.88, "targetMedianPrice": 25.0, "recommendationMean": 3.1, "recommendationKey": "hold", "numberOfAnalystOpinions": 8, "totalCash": 296927008, "totalCashPerShare": 3.827, "ebitda": 356384000, "totalDebt": 2011405952, "quickRatio": 1.75, "currentRatio": 3.388, "totalRevenue": 1566507008, "debtToEquity": 131.105, "revenuePerShare": 20.041, "returnOnAssets": 0.03509, "returnOnEquity": 0.0147, "freeCashflow": 112644752, "operatingCashflow": 141676992, "revenueGrowth": 0.097, "grossMargins": 0.59971, "ebitdaMargins": 0.2275, "operatingMargins": 0.11281, "financialCurrency": "USD", "trailingPegRatio": 0.6516, "__fetch_time": "2024-10-17"}]